Universal Time: 18:43  |  Local Time: 18:43 (0h GMT)
Select your timezone:
Room: E-Poster Hall

P-2.41 The effects of a novel drug, PQA 18, on small intestinal transplantation

Tasuku Kodama, Japan

Gratuate student
Pediatric Surgery
Osaka University Graduate School of Medicine


The effect of a PAK-2 inhibitor on macrophage differentiation/polarization in a rat small intestinal transplantation model

Tasuku Kodama1, Akira Maeda1, Phei-chi Lo1, Takehisa Ueno1, Yuko Tazuke1, Hiroshi Eguchi1, Katsuyoshi Matsunami2, Shuji Miyagawa1, Hiroomi Okuyama1.

1Pediatric Surgery, Osaka University Graduate School of Medicine, Suita, Japan; 2Pharmacognosy, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan

Introduction: PQA-18 (prenylquinoline carboxy derivative 18) is a novel immunosuppressant that inhibits PAK-2 and suppresses cytokine production and macrophage (Mφ) differentiation/proliferation. The effect of PQA-18 was evaluated using a rat small intestine transplant model.
Methods: Male Dark Agouti (DA) (RT-1a) and Lewis (RT-1l) rats, 7 to 9 weeks old, were used as donors and recipients, respectively.  An approximately 15 cm ileal grafts from the donor was heterotopically transplanted to the recipient rats.  Recipients were administered PQA-18 (4 mg/kg/day) intraperitoneal injection from post-operative day1 (POD1) for two weeks.
(1) The survival time of the graft was compared between the non-administration group (ITx-g) and the PQA administered group (PQA-g).  The rejection was manifested by progressive stoma ischemia, necrosis and the development of an abdominal mass, based on our previous studies.
(2) At POD6, CD3 + T cells were separated from recipient mesenteric lymph nodes and mixed lymphocyte reaction (MLR) was performed.
(3) Further, the % of Mφ in the graft mesenteric lymph node (gMLN) and graft Peyer's patch (gPP) was measured by FACS.
(4) Bone marrow stem cells of Lewis rat were cultured with G-CSF for 4 days, with or without PQA-18, and the differentiation/proliferation of Mφ was also measured by FACS.
Results: (1) The graft survival time was prolonged from 7.0 ± 0.77 days in ITx-g (n = 9) to 10.7 ± 1.26 days in PQA-g (n = 10) (p <0.001).  However, there was no difference between the two groups in serum creatinine and BUN on POD10 and POD14, measured for the evaluation of renal function.
(2) MLR showed a suppression of T cell proliferation in PQA-g compared with ITx-g: 9.44 ± 1.21 vs 4.71 ± 0.55 (n = 4) (p <0.05), respectively.
(3) The % of Mφ in the graft was 60.55 ± 2.18% (ITx-g) vs 45.20 ± 3.20% (PQA-g)(n = 6) (p <0.01) for gMLN and 42.42 ± 3.61% (ITx-g) vs 29.8% ± 3.21% (PQA-g) (n = 6) for gPP (p <0.05).  In addition, the decreation of Mφ was observed in all cases of PQA-g.
(4) The % of Mφ differentiation was reduced in the dose dependent manner.  The group with 20μM of PQA-18 showed 5.01 ± 2.09% (n = 6), vs 14.45 ± 2.40% (control) (p <0.05).
Conclusion: PQA-18 significantly prolonged the survival of rat small intestinal grafts by suppressing the Mφ infiltration in the grafts and lymph nodes.

JSPS KAKENHI Grant Number JP17K17001.


There are no comments yet...

WebApp Sponsor

© 2021 TTS 2020